Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice

Journal of Clinical Investigation

Volumn 101, Issue 8, 1998, Pages 1717-1725

  Zhou, Xinghua ^a   Paulsson, Gabrielle ^a   Stemme, Sten ^a   Hansson, Göran K ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atherosclerosis; Autoantibodies; Cytokines; Lipoprotein oxidation; T lymphocytes

Indexed keywords

APOLIPOPROTEIN E; AUTOANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 4; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; ATHEROSCLEROSIS; AUTOIMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HELPER CELL; HYPERCHOLESTEROLEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE;

EID: 0032522995     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1216     Document Type: Article

References (53)

1. Steinberg, D., S. Parthasarathy, T.E. Carew, J.C. Khoo, and J.L. Witztum. 1989. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:915-924.
2. Witztum, J.L., and D. Steinberg. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88:1785-1792.
3. Terkeltaub, R., C.L. Banka, J. Solan, D. Santoro, K. Brand, and L.K. Curtiss. 1994. Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. Arterioscler. Thromb. 14: 47-53.
4. Quinn, M.T., S. Parthasarathy, L.G. Fong, and D. Steinber. 1987. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc. Natl. Acad. Sci. USA. 84:2995-2998.
5. Kume, N., M.I. Cybulsky, and M.A. Gimbrone. 1992. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Invest. 90:1138-1144.
6. Frostegård, J., J. Nilsson, A. Haegerstrand, A. Hamsten, H. Wigzell, and M. Gidlund. 1990. Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc. Natl. Acad. Sci. USA. 87:904-908.
7. Cathcart, M.K., D.W. Morel, and G.M. Chisolm. 1985. Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic. J. Leukocyte. Biol. 38:341-350.
8. Krieger, M., S. Acton, J. Ashkenas, A. Pearson, M. Penman, and D. Resnick. 1993. Molecular flypaper, host defense, and atherosclerosis. J. Biol. Chem. 268:4569-4572.
9. Stemme, S., B. Faber, J. Holm, O. Wiklund, J.L. Witztum, and G.K. Hansson. 1995. T lymphocytes from human atherosclerotic plaques recognize oxidized LDL. Proc. Natl. Acad. Sci. USA. 92:3893-3897.
10. Smith, J.D., E. Trogan, M. Ginsberg, C. Grigaux, J. Tian, and M. Miyata. 1995. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc. Natl. Acad. Sci. USA. 92:8264-8268.
11. Gupta, S., A.M. Pablo, X.-c. Jiang, N. Wang, A.R. Tall, and C. Schindler. 1997. IFN-γ potentiates atherosclerosis in ApoE knock-out mice. J. Clin. Invest. 99:2752-2561.
12. Dansky, H.M., S.A. Charlton, M.M. Harper, and J.D. Smith. 1997. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. USA. 94:4642-4646.
13. Roselaar, S.E., G. Schonfeld, and A. Daugherty. 1995. Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity. J. Clin. Invest. 96:1389-1394.
14. Paton, P., A. Tabib, R. Loire, and R. Tete. 1993. Coronary artery lesions and human immunodeficiency virus infection. Res. Virol. 144:225-231.
15. Capron, L., Y.U. Kim, C. Laurian, P. Bruneval, and J.N. Fiessinger. Atheroembolism in HIV-positive individuals. Lancet. 340:1039-1040.
16. Marks, C., and S. Kuskov. Pattern of arterial aneurysms in acquired immunodeficiency disease. World J. Surg. 19:127-132.
17. Ylä-Herttuala, S., W. Palinski, S.W. Butler, S. Picard, D. Steinberg, and J.L. Witztum. 1994. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler. Thromb. 14:32-40.
18. Palinski, W., M.E. Rosenfeld, S. Ylä-Herttuala, G.C. Gurtner, S.A. Socher, S.W. Butler, S. Parthasarathy, T.E. Carew, D. Steinberg, and J.L. Witztum. 1989. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA. 86:1372-1376.
19. Bergmark, C., R. Wu, U. de Faire, A.K. Lefvert, and J. Swedenborg. 1995. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arterioscler. Thromb. Vasc. Biol. 15: 441-445.
20. Salonen, J.T., S. Ylä-Herttuala, R. Yamamoto, S. Butler, H. Korpela, R. Salonen, K. Nyyssänen, W. Palinski, and J.L. Witztum. 1992. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet. 339: 883-887.
21. Palinski, W., S. Hörkkö, E. Miller, U.P. Steinbrecher, H.C. Powell, L.K. Curtiss, and J.L. Witztum. 1996. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J. Clin. Invest. 98:800-814.
22. Palinski, W., E. Miller, and J.L. Witztum. 1995. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc. Natl. Acad. Sci. USA. 92: 821-825.
23. Ameli S., A. Hultgårdh-Nilsson, J. Regnström, F. Calara, J. Yano, B. Cercek, P.K. Shah, and J. Nilsson. 1996. Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler. Thromb. Vasc. Biol. 16:1074-1079.
24. Nityanand, S., C. Bergmark, U. de Faire, J. Swedenborg, G. Holm, and A.K. Lefvert. 1995. Antibodies against endothelial cells and cardiolipin in young patients with peripheral atherosclerotic disease. J. Int. Med. 238:437-443.
25. Uusitupa, M.I.J., L. Niskanen, J. Luoma, P. Vilja, M. Mercuri, R. Rauramaa, and S. Ylä-Herttuala. 1996. Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. Arterioscler. Thromb. Vasc. Biol. 16:1236-1242.
26. Nakashima, Y., A.S. Plump, E.W. Raines, J.L. Breslow, and R. Ross, 1994. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14:133-140.
27. Piedrahita, J.A., S.H. Zhang, J.R. Hagaman, P.M. Oliver, and N. Maeda. 1992. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. USA. 89:4471-4475.
28. Plump, A.S., J.D. Smith, T. Hayek, K. Aalto-Setälä, A. Walsh, J.G. Verstuyft, E.M. Rubin, and J.L. Breslow. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:343-353.
29. Zhou, X., S. Stemme, and G.K. Hansson. 1996. Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apo E-deficient mice. Am. J. Pathol. 149:359-366.
30. Daugherty, A., E. Purè. D. Delfel-Butteiger, J. Leferovich, and S.E. Roselaar. 1997. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E -/-mice. J. Clin. Invest. 100:1575-1580.
31. Palinski, W., V. Ord, A.S. Plump, J.L. Breslow, D. Steinberg, and J.L. Witztum. 1994. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis: demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler. Thromb. 14:605-616.
32. Palinski, W., S. Ylä-Herttuala, M.E. Rosenfeld, S.W. Butler, S.A. Socher, S. Parthasarathy, L.K. Curtiss, and J.L. Witztum. 1990. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arterioscler. Thromb. 10:325-335.
33. Zinkernagel, R.M., and P.C. Doherty. 1974. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic and semiallogeneic system. Nature. 248:701-702.
34. Matis, L.A. 1990. The molecular basis of T cell specificity. Annu. Rev. Immunol. 8:65-82.
35. Snapper, C.M., and F.D. Finkelman. 1993. Immunoglobulin class switching. In Fundamental Immunology. 3rd ed. W.E. Paul, editor. Raven Press, Ltd., New York. 837-863.
36. Sander, B., I. Hoiden, U. Andersson, E. Möller, J.S. Abrams. 1993. Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen. Cytokine detection by immunoassays and intracellular immunostaining. J. Immunol. Methods. 166:201-214.
37. Jonasson, L., J. Holm, O. Skalli, G. Bondjers, and G.K. Hansson. 1986. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 6:131-138.
38. Roselaar, S.E., P.X. Kakkanathu, A. Daugherty. 1996. Lymphocyte populations in atherosclerotic lesions of apo E -/-and LDL receptor -/-mice. Decreasing density with disease progression. Arterioscler. Thromb. Vasc. Biol. 16:1013-1018.
39. Hansson, G.K. 1994. Immunological control mechanisms in plaque formation. Basic. Res. Cardiol. 1:41-46.
40. Hansson, G.K., and P. Libby. 1995. The role of the lymphocyte. In Atherosclerosis and Coronary Artery Disease. Vol. 1. V. Fuster, R. Ross, and E.J. Topol, editors. Lippincott-Raven Publishers, Philadelphia/NewYork. 557-568.
41. Hansson, G.K. 1997. Cell-mediated immunity in atherosclerosis. Curr. Opin. Lipidol. 8:301-311.
42. Hansson, G.K., J. Holm, and L. Jonasson. 1989. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am. J. Pathol. 135:169-175.
43. Geng, Y.J., J. Holm, S. Nygren, M. Bruzelius, S. Stemme, and G.K. Hansson. 1995. Expression of macrophage scavenger receptor in atherosclerosis. Relationship between scavenger receptor isoforms and the T cell cytokine, interferon-γ. Arterioscler. Thromb. Vasc. Biol. 15:1995-1202.
44. Hansson, G.K., V. Stemme, and T. Yokota. 1997. Cytokines and the cardiovascular system. In Cytokines in Health and Disease. 2nd ed. D. Remick and J. Friedland, editors. Lippincott-Raven Publishers, Philadelphia. 507-517.
45. Mosmann, T.R., and R.L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
46. Romagnani, S. 1997. The Th1/Th2 paradigm. Immunol. Today. 18:263-266.
47. Paigen, B., A. Morrow, C. Brandon, D. Mitchell, and P.A. Holmes. 1985. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis. 57:65-73.
48. Uyemura, K., L. Demer, S.C. Castle, D. Jullien, J.A. Berliner, M.K. Gately, R.R. Warrier, N. Pham, A.M. Fogelman, R.L. Modlin. 1996. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J. Clin. Invest. 97:2130-2138.
49. Hosken, N.A., K. Shibuya, A.W. Heath, K.M. Murphy, and A. O'Garra. 1995. The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-αβ transgenic model. J. Exp. Med. 182:1579-1584.
50. Constant, S.L., and K. Bottomly. 1997. Induction of CD4+ T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:297-322.
51. Hamilton, T.A., G.P. Ma, and G.M. Chisolm. 1990. Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-alpha mRNA in stimulated murine peritoneal macrophages. J. Immunol. 144:2343-2350.
52. Witztum, J.L. 1993. Murine models for study of lipoprotein metabolism and atherosclerosis. J. Clin. Invest. 92:536-537.
53. Romagnani, S. 1994. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12:227-257.